Can a single pill ease pain after liver cancer procedure?
NCT ID NCT03151213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving a single dose of pregabalin before a liver cancer ablation procedure can reduce pain afterward. 70 adults with liver cancer were randomly assigned to receive either pregabalin or a placebo before their procedure. The main goal was to measure pain levels after the procedure using a standard pain scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pregabalin
- What this could lead to
- If it works, this could offer a simple way to reduce pain after liver cancer ablation, improving recovery comfort.
- What could go wrong
- This is a small, completed Phase 4 trial with only 70 participants. The benefit may be modest and not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tanta university - faculty of medicine
Cairo, Elgharbia, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new test could reveal how radiation affects the liver
- Gut bacteria transplant may supercharge liver cancer immunotherapy
- Engineered immune cells take on liver cancer in early trial
- New drug MDX2001 tested in 285 patients with advanced cancers
- Can a simple blood test predict cancer return? new study investigates
- Blow into this tube: a simple breath test might spot liver disease early